NCT05810441View on ClinicalTrials.gov

Intestinal Transglutaminase Antibodies in Celiac Disease Diagnosis

CompletedOBSERVATIONAL
Enrollment

213

Participants

Timeline

Start Date

September 23, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Celiac Disease
Interventions
OTHER

Evaluation of diagnostic accuracy of anti-ttg-m

Mucosal anti-ttg evaluated in intestinal biopsy samples

Trial Locations (1)

34137

IRCCS materno infantile Burlo Garofolo, Trieste

All Listed Sponsors
lead

IRCCS Burlo Garofolo

OTHER

NCT05810441 - Intestinal Transglutaminase Antibodies in Celiac Disease Diagnosis | Biotech Hunter | Biotech Hunter